Drug firm Lupin on Thursday said it has received a warning letter from the US health regulator for its Tarapur-based manufacturing facility in Maharashtra. The US Food and Drug Administration (USFDA) inspected the site from March 22, 2022 to April 4, 2022.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ty90teR
via IFTTT
0 comments:
Post a Comment